Cargando…
Acetylshikonin Inhibits Human Pancreatic PANC-1 Cancer Cell Proliferation by Suppressing the NF-κB Activity
Acetylshikonin, a natural naphthoquinone derivative compound, has been used for treatment of inflammation and cancer. In the present study, we have investigated whether acetylshikonin could regulate the NF-κB signaling pathway, thereby leading to suppression of tumorigenesis. We observed that acetyl...
Autores principales: | Cho, Seok-Cheol, Choi, Bu Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556202/ https://www.ncbi.nlm.nih.gov/pubmed/26336582 http://dx.doi.org/10.4062/biomolther.2015.102 |
Ejemplares similares
-
Acetylshikonin suppressed growth of colorectal tumour tissue and cells by inhibiting the intracellular kinase, T‐lymphokine‐activated killer cell‐originated protein kinase.
por: Zhao, Ran, et al.
Publicado: (2020) -
Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivo
por: Cheng, Hao, et al.
Publicado: (2017) -
Silencing of Carboxypeptidase E expression inhibits proliferation and invasion of Panc-1 pancreatic cancer cells
por: Lou, Hong, et al.
Publicado: (2022) -
Glycolysis in Panc-1 human pancreatic cancer cells is inhibited by everolimus
por: LIU, LING, et al.
Publicado: (2013) -
Pharmacology, toxicity and pharmacokinetics of acetylshikonin: a review
por: Zhang, Zhiqin, et al.
Publicado: (2020)